A detailed history of Vision Point Advisory Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Vision Point Advisory Group, LLC holds 5,016 shares of AMGN stock, worth $1.4 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
5,016
Previous 4,135 21.31%
Holding current value
$1.4 Million
Previous $1.29 Million 25.17%
% of portfolio
0.59%
Previous 0.48%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$309.38 - $337.38 $272,563 - $297,231
881 Added 21.31%
5,016 $1.62 Million
Q2 2024

Aug 01, 2024

BUY
$262.75 - $319.31 $160,277 - $194,779
610 Added 17.3%
4,135 $1.29 Million
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $488,536 - $589,725
1,817 Added 106.38%
3,525 $1 Million
Q4 2023

Feb 07, 2024

BUY
$255.7 - $288.46 $268,229 - $302,594
1,049 Added 159.18%
1,708 $491,000
Q3 2023

Dec 06, 2023

BUY
$218.65 - $271.46 $116,759 - $144,959
534 Added 427.2%
659 $177,000
Q2 2023

Aug 21, 2023

BUY
$214.27 - $253.37 $26,783 - $31,671
125 New
125 $27,000
Q3 2021

Nov 08, 2021

SELL
$212.27 - $248.7 $1.29 Million - $1.51 Million
-6,085 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $472,765 - $524,499
-2,024 Reduced 24.96%
6,085 $1.48 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $176,640 - $205,845
-796 Reduced 8.94%
8,109 $2.02 Million
Q4 2020

Feb 08, 2021

BUY
$216.38 - $257.67 $1.93 Million - $2.29 Million
8,905 New
8,905 $2.05 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Vision Point Advisory Group, LLC Portfolio

Follow Vision Point Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vision Point Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vision Point Advisory Group, LLC with notifications on news.